This inventor holds 1 USPTO granted patent. Top assignee: C4 Therapeutics, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Liwei Zhang: Innovator in Targeted Protein Degradation
Introduction
Liwei Zhang is a prominent inventor based in Watertown, MA (US). He has made significant contributions to the field of targeted protein degradation, particularly through his work on BRD9 protein. His innovative approach aims to address disorders mediated by BRD9, which includes abnormal cellular proliferation.
Latest Patents
Liwei Zhang holds a patent for "Selected compounds for targeted degradation of BRD9." This patent encompasses selected BRD9 protein degradation compounds and their morphic forms, which are crucial for developing treatments for various disorders.
Career Highlights
Liwei Zhang is currently associated with C4 Therapeutics, Inc., where he continues to advance his research and development efforts. His work is pivotal in the ongoing exploration of targeted therapies that can significantly impact patient outcomes.
Collaborations
Liwei collaborates with notable colleagues, including Katrina L. Jackson and Christopher G. Nasveschuk. Their combined expertise enhances the innovative environment at C4 Therapeutics, Inc.
Conclusion
Liwei Zhang's contributions to the field of targeted protein degradation exemplify the impact of innovative research on medical science. His work continues to pave the way for new therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile